Daily non-political popular news in brief.
Progress toward a targeted therapy for a specific form of leukemia
04-15-2007 · EurekAlert!Leukemia strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T cell acute lymphoblastic leukemia, or T-ALL. Now, VIB researchers connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10 percent of the T-ALL cases: MYB.
Read more »
Keywords: progress, toward, targeted, therapy, specific, form, leukemia
« Previous | Next »
Similar news on "Progress toward a targeted therapy for a specific form of leukemia":
- Firefly genes allow testing of new therapy against lymphoma
12-19-2007 · EurekAlert!
Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
Similar news · Read more »
- St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
08-29-2007 · EurekAlert!
Results of a study by investigators at St. Jude Children’s Research Hospital provide strong evidence for why the targeted therapy drug, imatinib, or Gleevec™, which has revolutionized the treatment of chronic myelogenous leukemia, (CML) is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
Similar news · Read more »
- Scientists identify fundamental brain defect, probable drug target in fragile X syndrome
09-17-2007 · EurekAlert!
Scientists have discovered how the gene mutation responsible for fragile X syndrome -- the most common inherited form of mental retardation -- alters the way brain cells communicate. In neurons cultured from laboratory rats, the scientists also were able to reverse the effects of the mutation using a drug targeted to the specific site in an upstream pathway of the defect. The finding could lead to the development of human therapies for this previously untreatable condition.
Similar news · Read more »
- Epigenetic drugs, promising for breast cancer treatment
12-20-2006 · EurekAlert!
Worldwide, cancer persists as one of the most important diseases that affect the human being. The knowledge on the molecular bases of cancer generated during the last decades has been successfully translated into small but significant gains in overall cancer survival rates due to better primary prevention measures, improved diagnostic methods and the development of more effective and specific therapies, collectively termed "molecular targeted therapies." In the context of these new forms of treatment, epigenetic or transcriptional cancer therapy is clearly promising.
Similar news · Read more »
- Targeted cancer drugs may work by disrupting balance of cellular signals
11-13-2006 · EurekAlert!
Targeted cancer therapy drugs like Gleevec and Tarceva, which destroy tumors by interfering with specific proteins or protein pathways, may disrupt the balance between critical cellular signals in a way that leads to cell death.
Similar news · Read more »
- Nerve fibers need specific growth factor chemical to form connections within the brain
11-17-2006 · EurekAlert!
A discovery on how neural circuitry develops to aid proper cerebral cortex activity may help explain the memory and cognitive decline seen in Alzheimer's disease patients -- a discovery that could point toward potential treatments, according to UC Irvine scientists.
Similar news · Read more »
- UF scientists identify cancer virus' genetic targets
05-10-2007 · EurekAlert!
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin.
Similar news · Read more »
- OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
12-10-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days.
Similar news · Read more »
- Targeted tumor therapy: When antagonists do the better job
10-19-2006 · EurekAlert!
Targeted tumor therapy lobs toxic payloads directly into tumors to destroy cancer cells while leaving normal cells unharmed. These missiles, which should unerringly home in on the target and make it implode, consist of lethal payloads guided by small molecules -- known as agonists -- that recognize and then activate specific receptors over-expressed on the surface of tumor cells. A new study shows that it may be better to exploit small molecules that antagonize rather than activate receptors.
Similar news · Read more »
- Batten down the hatches against HIV
02-20-2007 · EurekAlert!
A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein. A stumbling block has been the efficient and targeted delivery of RNA into the cells. Researchers led by Hongjie Dai at Stanford University have sucessfully used carbon nanotubes as a "means of transport," they write in "Angewandte Chemie."
Similar news · Read more »
